Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Auxilius
AddedFeb 17, 2024
UpdatedJun 18, 2026
Auxilius

Auxilius

Series A

Data-driven platform, Auxilius, optimizes biotech trial costs and manages financial risks for efficient outcomes.

HQ
New York City, NY, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Auxilius, founded to revolutionize financial management in clinical trials, focuses on helping biotech companies control trial costs, manage financial risks, and optimize spending to meet trial targets. Their data-driven platform is designed specifically for the biopharma industry, providing tools for accurate forecasting, budgeting, and accrual management. Auxilius aims to integrate financial management seamlessly into the clinical trial process, ensuring that financial oversight contributes to the overall success of drug development.

Notable figures associated with Auxilius include key biopharma industry experts and investors who have recognized the platform's potential to transform clinical trial financial management. The company has achieved significant milestones, such as being trusted by leading biopharma teams and auditors for their robust financial solutions. Auxilius has made a substantial impact by enabling more efficient and effective financial oversight in clinical trials, ultimately supporting the development of new therapies and contributing to advancements in healthcare.

Auxilius - Similar Companies

Miracle logo

Miracle

miracleml.com

Algorics logo

Algorics

Aimably logo

Aimably

aimably.com

On-Time Trials logo

On-Time Trials

ontimetrials.com

iClinical logo

iClinical

Strategikon Pharma logo

Strategikon Pharma

The Concinnity Company logo

The Concinnity Company

Aithentic logo

Aithentic

aithentic.com

UpCompany logo

UpCompany

Innovu logo

Innovu

innovu.com

ApexEdge logo

ApexEdge

apexedge.com

Confido logo

Confido

confidotech.com

Arpari logo

Arpari

arpari.com

AidBanc logo

AidBanc

aidbanc.com

TrialSpark logo

TrialSpark

trialspark.com

Auxilius - Quick Facts

Who are Auxilius' competitors?

Companies similar to Auxilius include Miracle, Algorics, Aimably and On-Time Trials.

When was Auxilius founded?

Auxilius was founded in 2020.

Where is Auxilius' headquarters located?

Auxilius' headquarters is located in New York City, NY, US.

When was Auxilius' last funding round?

Auxilius' most recent funding round was for $10M (USD) in June 2022.

How much has Auxilius raised to-date?

As of Jun 16, 2022, Auxilius has raised a total of $10M (USD).

How many employees does Auxilius have?

Auxilius has 38 employees as of Feb 4, 2024.

Auxilius - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Analytics
  • Data
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Financial Management
Tags
  • Consulting
  • Fintech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software